| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 203.66B | 197.00B | 174.90B | 178.33B | 156.29B | 214.99B |
| Gross Profit | 26.67B | 25.69B | 22.92B | 25.08B | 25.77B | 18.57B |
| EBITDA | 13.16B | 13.29B | 9.71B | 14.00B | 15.82B | 9.54B |
| Net Income | 4.78B | 4.80B | 1.60B | 5.49B | 7.51B | 2.86B |
Balance Sheet | ||||||
| Total Assets | 195.82B | 196.63B | 182.89B | 191.89B | 176.44B | 147.92B |
| Cash, Cash Equivalents and Short-Term Investments | 20.77B | 18.76B | 21.47B | 26.99B | 26.69B | 27.05B |
| Total Debt | 54.27B | 53.74B | 55.20B | 71.82B | 61.80B | 59.12B |
| Total Liabilities | 127.18B | 126.32B | 116.54B | 128.84B | 119.11B | 104.55B |
| Stockholders Equity | 68.06B | 69.70B | 65.75B | 62.52B | 56.87B | 42.85B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 463.00M | 11.77B | -4.56B | -7.59B | 1.04B |
| Operating Cash Flow | 0.00 | 7.00B | 15.21B | 226.00M | -3.33B | 4.10B |
| Investing Cash Flow | 0.00 | -4.71B | -2.62B | -7.04B | -3.26B | -2.47B |
| Financing Cash Flow | 0.00 | -4.80B | -19.28B | 5.90B | 5.76B | 2.85B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥120.37B | 7.91 | 11.58% | 1.98% | 9.81% | 30.20% | |
74 Outperform | ¥65.97B | 13.75 | ― | 3.48% | 8.89% | 102.20% | |
72 Outperform | ¥17.06B | 8.87 | ― | 4.43% | -0.87% | 13.44% | |
67 Neutral | ¥95.16B | 20.18 | ― | 0.99% | -3.56% | -30.17% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
57 Neutral | ¥97.51B | 28.35 | 5.78% | 1.38% | 0.82% | -1.72% | |
56 Neutral | ¥38.26B | ― | ― | 9.52% | -35.81% | -138.00% |
ALCONIX Corporation reported its consolidated financial results for the first quarter of the fiscal year ending March 31, 2026, showing a 14.5% increase in net sales compared to the previous year. Despite the rise in sales, the company experienced a slight decline in ordinary profit and profit attributable to owners of the parent, indicating challenges in maintaining profitability amidst growing sales. The company’s equity ratio slightly decreased, reflecting changes in its financial position, while the dividend forecast remains unchanged, suggesting stability in shareholder returns.
ALCONIX Corporation has completed the payment procedures for the issuance of 21,900 new shares as restricted stock compensation, aimed at aligning the interests of its directors and executive officers with the company’s performance. This move is expected to strengthen the company’s governance structure and incentivize its leadership team, potentially impacting its market positioning positively.